Journal article
PKPD model of interleukin-21 effects on thermoregulation in monkeys - Application and evaluation of stochastic differential equations
Purpose To describe the pharmacodynamic effects of recombinant human interleukin-21 (IL-21) on core body temperature in cynomolgus monkeys using basic mechanisms of heat regulation. A major effort was devoted to compare the use of ordinary differential equations (ODEs) with stochastic differential equations (SDEs) in pharmacokinetic pharmacodynamic (PKPD) modelling.
Methods A temperature model was formulated including circadian rhythm, metabolism, heat loss, and a thermoregulatory set-point. This model was formulated as a mixed-effects model based on SDEs using NONMEM. Results The effects of IL-21 were on the set-point and the circadian rhythm of metabolism. The model was able to describe a complex set of IL-21 induced phenomena, including 1) disappearance of the circadian rhythm, 2) no effect after first dose, and 3) high variability after second dose.
SDEs provided a more realistic description with improved simulation properties, and further changed the model into one that could not be falsified by the autocorrelation function. Conclusions The IL-21 induced effects on thermoregulation in cynomolgus monkeys are explained by a biologically plausible model.
The quality of the model was improved by the use of SDEs.
Language: | English |
---|---|
Publisher: | Kluwer Academic Publishers-Plenum Publishers |
Year: | 2007 |
Pages: | 298-309 |
Journal subtitle: | An Official Journal of the American Association of Pharmaceutical Scientists |
ISSN: | 1573904x and 07248741 |
Types: | Journal article |
DOI: | 10.1007/s11095-006-9143-x |
ORCIDs: | Madsen, Henrik |
Algorithms Animals Biochemistry, general Biomedical Engineering Biomedicine Body Temperature Regulation Circadian Rhythm Computer Simulation Data Interpretation, Statistical Fever Interleukins Likelihood Functions Macaca fascicularis Male Medical Law Metabolism Models, Statistical Pharmacology/Toxicology Pharmacy Receptors, Drug Stochastic Processes interleukin-21